Related Experiment Video
Updated: Mar 25, 2026

11:00
Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
18.0K
Same-Slide Spatial Multiomics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the
Stephanie Pei Tung Yiu1, Yuzhou Chang1,2,3, Yao Yu Yeo1,4
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Cancer Discovery
|March 24, 2026
Summary
IN-DEPTH is a new spatial multi-omics workflow. It integrates spatial proteomics and transcriptomics to reveal cellular interactions and mechanisms in diffuse large B-cell lymphoma (DLBCL) at single-cell resolution.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Computational Biology
Background:
- Spatial transcriptomics and proteomics offer insights into tissue organization but are often disparate.
- Current same-slide multi-omics methods face limitations in multiplexing, resolution, signal retention, and integration.
- There is a need for advanced techniques to bridge spatial proteomics and transcriptomics for deeper biological understanding.
Purpose of the Study:
- To introduce IN-situ DEtailed Phenotyping To High-resolution transcriptomics (IN-DEPTH), a novel workflow for integrated spatial multi-omics.
- To develop Spectral Graph Cross-Correlation (SGCC) for analyzing proteomic and transcriptomic data to identify spatially coordinated cellular states.
- To apply IN-DEPTH and SGCC to diffuse large B-cell lymphoma (DLBCL) to uncover microenvironmental mechanisms.
Main Methods:
- Developed IN-DEPTH, a streamlined workflow using spatial proteomics imaging to guide transcriptomic capture on the same slide.
- Implemented Spectral Graph Cross-Correlations (SGCC), a framework for integrating proteomic and transcriptomic data.
- Applied the workflow to study EBV-positive and EBV-negative diffuse large B-cell lymphoma (DLBCL) samples.
Main Results:
- IN-DEPTH preserves RNA signal during integrated proteomic and transcriptomic analysis.
- SGCC enabled the resolution of spatially coordinated functional states in interacting cell populations.
- Analysis of DLBCL revealed coordinated tumor-macrophage-CD4 T-cell remodeling, C1Q macrophage enrichment, CD4 T-cell dysfunction, and a potential IL-27-STAT3 signaling axis.
Conclusions:
- IN-DEPTH provides a scalable approach for high-resolution spatial multi-omics.
- The integrated analysis uncovered key microenvironmental mechanisms in DLBCL.
- This methodology facilitates the development of robust spatial multi-modal AI models for clinical insights.
Related Concept Videos
The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
The Tumor Microenvironment
3.0K
3.0K
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression
3.5K
3.5K

